Cue health ipo prediction
WebSAN DIEGO, California, September 23, 2024– Cue Health Inc. (“Cue Health”) (Nasdaq: HLTH), a health technology company, today announced the pricing of its initial public offering of 12,500,000 shares of its common stock at a public offering price of $16.00 per share, for gross proceeds of $200.00 million, before deducting underwriting discounts … WebSep 24, 2024 · Sep. 23, 2024, 08:59 PM. SAN DIEGO, Sept. 23, 2024 /PRNewswire/ -- Cue Health Inc. ("Cue Health") (Nasdaq: HLTH), a health technology company, today announced the pricing of its initial public ...
Cue health ipo prediction
Did you know?
WebBased on 4 Wall Street analysts offering 12 month price targets for Cue Health in the last 3 months. The average price target is $5.38 with a high forecast of $8.00 and a low forecast of $3.50. The average price target represents a 186.17% change from the last price of $1.88. Highest Price Target $8.00. Average Price Target $5.38.
WebCue Health’s (HLTH) Stock Forecast: Where Will It Be in 2025? Health (Just Now) WebThe company priced its IPO at $16 a share, at the midpoint of its targeted range of $15–$17. The stock opened above $16 and peaked at $22.55. If … WebSep 27, 2024 · The Cue Health IPO paperwork provides a look inside the previously closed off private company. Cue Health began generating revenue from product sales in August 2024 following the receipt of its first FDA emergency use authorization for its 20-minute molecular COVID-19 test in June 2024.
WebDec 4, 2024 · Cue Health, a startup that makes handheld coronavirus tests, is in discussion with investors about a new round of capital that could boost the company’s valuation to more than $2 billion, or at least four times the … WebSep 24, 2024 · Cue Health Inc. HLTH, +7.73% received a warm reception on Wall Street Friday, as the stock opened 4.8% above its initial public offering price, and kept rising. The California-based COVID-19 test ...
WebSep 24, 2024 · Sept. 24, 2024 4:15 PM PT San Diego’s Cue Health, which has seen explosive demand for its 20-minute COVID-19 tests from the military, the NBA, Google and others, became the region’s latest...
WebPMW sidelines two programs as lead tumor suppressor candidate picks up pace in clinic. Mar 1, 2024 12:00pm. lithonia esxfWebSep 27, 2024 · The company priced its IPO at $16 a share, at the midpoint of its targeted range of $15–$17. The stock opened above $16 and peaked at $22.55. If Cue Health can keep reporting impressive... lithonia esxf2WebSep 2, 2024 · Just eight months into the year, IPO activity has already reached all-time highs, with tech firms and biotechnology startups leading the rally. Cue Health, Inc. is the latest healthcare company to join the IPO bandwagon, after registering strong revenue growth in recent months. $100 Mln IPO The San Diego-headquartered provider of … lithonia esf18WebApr 7, 2024 · Cue Health Inc. Today's Change (0.54%) $0.01 Current Price $1.87 Key Data Points Market Cap $283M Day's Range $1.82 - $1.88 52wk Range $1.63 - $7.25 Volume … imuran for ildWebSep 24, 2024 · “We anticipate growing our manufacturing capacity to a rate equivalent to tens of millions of Cue Cartridges per year by the end of 2024,” the filing said. Cue … lithonia esx1WebApr 5, 2024 · HLTH Stock Overview. Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, … imuran and methotrexateWebSep 27, 2024 · Based on its corporate disclosure, Cue Health distributed 12.5 million shares, resulting in gross proceeds of $200 million before deducting expenses associated with the market debut. Further,... imuran fertility